Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

New therapy for kidney patients wins innovation award

New blood filter therapy for kidney patients wins innovation award

A new haemodialysis (blood filter) therapy that has the potential to significantly advance renal (kidney) care for patients in New Zealand has won the James & Wells Medical Technology Association of New Zealand (MTANZ) Innovation Award for 2018.

Baxter Healthcare received the award for its HDx enabled by Theranova haemodialysis (HD) therapy from Jonathan Lucas, partner at James & Wells, at the Health Tech Week Gala Dinner last night (June 12).

More than 1700 New Zealanders receive haemodialysis treatment. Patients with end-stage renal disease on haemodialysis are at increased mortality risk compared to the general population.

Conventional haemodialysis is effective at removing small toxins, such as urea, but is ineffective at removing a class of uremic toxins known as large middle molecules. Large middle molecules may affect a range of biological functions, including inflammation, secondary immunodeficiency and cardiovascular (heart disease) risk.

Theranova is an innovative dialyser. It more closely mimics the natural kidney compared with other dialysis membranes. Theranova extends the range of toxins that can be filtered from the blood during haemodialysis for the first time without significant albumin loss. Once these toxins have been effectively removed, the patient is at less risk of infections and hospitalisation.

This technology is unique in New Zealand and global markets. The therapy is designed to work with most haemodialysis machines. This allows clinics to offer HDx therapy using existing resources and staff.



“MTANZ believes these awards, which are open to both imported and locally developed medical technology, show the tremendous innovation in the NZ health technology market. Innovation is so essential to deliver better outcomes for patients and improve efficiencies in the NZ healthcare system,” says MTANZ chief executive Faye Sumner, CNZM.

The awards were judged by Anne Kolbe ONZM, Distinguished Professor Peter Hunter ONZM and Professor John Windsor on the product’s significant contribution to improving patient outcomes by enhancing quality of life, as well as evidence of technical excellence and innovation.

The full list of finalists follows:

Medtronic – MicraTM Transcatheter Pacing System

Philips – Ilumeo imaging and informatics technology

Philips – IQon Spectral CT

ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Environment Aotearoa 2019: Report Warns Environment In Serious Trouble

The report says the way New Zealanders live and make a living is having a serious impact on the environment, and the benefits New Zealanders get from being in nature, though not measured or quantified, could be lost. More>>

ALSO:

Provincial Growth Fund: Backing Growth In Gore

“Today’s announcements are a $1.6 million investment towards the Maruawai precinct project, which involves the redevelopment of the Hokonui Moonshine Museum and creation of the Maruawai Heritage Centre...” More>>

ALSO:

Inflation: Cigarette Price Rise Offsets Cheaper Petrol

The consumers price index (CPI) rose 0.1 percent in the March 2019 quarter, due to higher prices for cigarettes, Stats NZ said today... In the year to March 2019, the inflation rate was 1.5 percent, down from 1.9 percent in the December 2018 year. More>>

ALSO:

Government Suppliers: MBIE Reinstates Fuji Xerox As A

The government has reinstated Fuji Xerox as a supplier despite an ongoing Serious Fraud Office investigation into accounting irregularities that led to losses of more than $300 million. More>>

ALSO: